Skip to main content

Table 3 Hepatologists’ attitude towards the use of radiological methods for diagnosis of significant fibrosis and cirrhosis

From: Role of liver biopsy versus non-invasive biomarkers for diagnosis of significant fibrosis and cirrhosis: a web-based survey

Variable

Patients (n = 573)

Are you familiar with radiological methods for non-invasive assessment of hepatic fibrosis? %

 Very familiar

58.12

 Familiar

37.30

 Not familiar

4.58

Do you think radiological methods are reliable for non-invasive assessment of hepatic fibrosis? %

 Extremely likely (100%)

10.89

 Very likely (75%)

51.20

 Moderately likely (50%)

32.90

 Slightly likely (25%)

4.58

 Not at all likely (0%)

0.44

Do you think radiological methods for non-invasive assessment of hepatic fibrosis are acceptable by patients? %

 Extremely likely (100%)

51.20

 Very likely (75%)

37.90

 Moderately likely (50%)

8.71

 Slightly likely (25%)

1.74

 Not at all likely (0%)

0.44

Do you think radiological methods for non-invasive assessment of hepatic fibrosis are easily applicable in clinical practice? %

 Extremely likely (100%)

32.68

 Very likely (75%)

45.1

 Moderately likely (50%)

18.52

 Slightly likely (25%)

3.27

 Not at all likely (0%)

0.44

Which radiological methods do you use for noninvasive assessment of hepatic fibrosis? “Please choose all that apply" %

 Ultrasound

59.48

 Computed tomography

26.58

 Magnetic resonance imaging

24.62

 FibroScan

85.40

 Ultrasound based elastography

25.05

 MRI-based elastography

8.71

What are the limitations of using radiological methods for the assessment of hepatic fibrosis? Please choose all that apply %

 Cost

47.06

 Exposure to radiation

14.38

 Availability

60.13

 Accuracy

45.53

 I don’t trust non-invasive methods

0.22

What is encouraging you for using radiological methods for the assessment of hepatic fibrosis? Please choose all that apply %

 Easy to use

87.58

 Less costly than liver biopsy

41.61

 Not convinced that liver biopsy is the gold standard

15.03

 Patient refusal for liver biopsy

64.27